Lew Iacovelli, PharmD | Authors

Clinical Management of EGFRI-Associated Dermatologic Toxicities: Pharmacy Perspective

October 01, 2007

This article describes agents used to treat the dermatologic toxicities commonly seen during therapy with epidermal growth factor receptor inhibitors. Therapeutic options include topical emollients, antibiotics, corticosteroids, and other agents for supportive care. While medical approaches to these adverse reactions are still in a "learning phase," continued experience will provide further insight into effective management strategies.